Wealth Enhancement Advisory Services LLC Takes Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 6,113 shares of the medical research company’s stock, valued at approximately $1,766,000.

Several other institutional investors and hedge funds have also modified their holdings of TMO. FMR LLC boosted its position in shares of Thermo Fisher Scientific by 33.5% during the 1st quarter. FMR LLC now owns 11,572,581 shares of the medical research company’s stock valued at $3,167,647,000 after acquiring an additional 2,900,868 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Thermo Fisher Scientific by 4.1% during the 1st quarter. BlackRock Inc. now owns 27,251,678 shares of the medical research company’s stock valued at $7,459,327,000 after buying an additional 1,074,400 shares in the last quarter. Marshall Wace LLP raised its holdings in shares of Thermo Fisher Scientific by 361.8% during the 1st quarter. Marshall Wace LLP now owns 775,103 shares of the medical research company’s stock valued at $212,161,000 after buying an additional 607,245 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of Thermo Fisher Scientific by 22.9% during the 2nd quarter. Janus Henderson Group PLC now owns 2,986,916 shares of the medical research company’s stock valued at $877,186,000 after buying an additional 555,802 shares in the last quarter. Finally, Swedbank purchased a new position in shares of Thermo Fisher Scientific during the 1st quarter valued at about $111,710,000. Hedge funds and other institutional investors own 88.21% of the company’s stock.

Thermo Fisher Scientific stock traded up $3.50 during trading hours on Thursday, reaching $272.98. The company had a trading volume of 65,669 shares, compared to its average volume of 1,592,969. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.07 and a current ratio of 1.49. The stock has a 50-day simple moving average of $287.70. The stock has a market cap of $108.93 billion, a price-to-earnings ratio of 24.60, a price-to-earnings-growth ratio of 1.78 and a beta of 1.11. Thermo Fisher Scientific Inc. has a 12-month low of $208.34 and a 12-month high of $305.45.



Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 24th. The medical research company reported $3.04 EPS for the quarter, topping the Zacks’ consensus estimate of $3.01 by $0.03. The business had revenue of $6.32 billion for the quarter, compared to analysts’ expectations of $6.31 billion. Thermo Fisher Scientific had a return on equity of 17.11% and a net margin of 14.24%. The business’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the firm earned $2.75 EPS. Analysts anticipate that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, September 17th will be paid a $0.19 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $0.76 dividend on an annualized basis and a yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 6.83%.

A number of equities analysts recently weighed in on the company. BTIG Research raised their price objective on Thermo Fisher Scientific to $320.00 and gave the company a “buy” rating in a report on Thursday, May 23rd. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 price objective on the stock in a report on Wednesday, June 12th. Barclays set a $330.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a report on Monday, July 15th. UBS Group raised their price objective on Thermo Fisher Scientific from $305.00 to $320.00 and gave the company a “buy” rating in a report on Thursday, May 23rd. Finally, Wolfe Research assumed coverage on Thermo Fisher Scientific in a report on Thursday, May 30th. They set an “outperform” rating on the stock. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $303.17.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total value of $14,241,500.00. Following the transaction, the chief executive officer now directly owns 342,193 shares of the company’s stock, valued at approximately $97,466,832.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $268.29, for a total value of $670,725.00. Following the completion of the transaction, the chief financial officer now directly owns 40,029 shares in the company, valued at $10,739,380.41. The disclosure for this sale can be found here. Insiders sold a total of 52,775 shares of company stock worth $14,986,676 over the last ninety days. Insiders own 0.45% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: What is Put Option Volume?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.